Indero supports phase I, proof of concept (POC), first-in-human (FIH) single center and multicenter studies, as well as molecular characterization and mechanistic studies.
Operational excellence is crucial for early phase trials, as introducing your product into the clinical space marks a significant and critical milestone in your program’s development.
Indero’s team of dermatology and rheumatology experts excel in managing and conducting complex early phase trials. We provide robust scientific and strategic support and have extensive experience in a wide array of study designs tailored to your needs.
Early phase trials mark your initial entry into the clinical space, where the primary goal is to evaluate the safety, tolerability, and efficacy of your investigational product or device. With Indero’s comprehensive experience in dermatology & rheumatology trials, we are the ideal partner for early phase studies that require precise methodological approaches and a deep understanding of immune-mediated conditions.
Partnering with us from the outset ensures that your initial steps are precise and well-guided, paving the way for your successful trial and program development. And as a true partner, our goal is to work with you from beginning to end throughout the development phases of your product.
We pride ourselves on being site and patient-focused, ensuring that every aspect of our early phase studies is designed with their needs in mind.
Sr. Director, Clinical Operations
Pelage Pharmaceuticals
“Indero’s flexibility and effective change management have been exceptional. They successfully integrated new study components, ensuring timelines were met and the project progressed seamlessly.”
Indero can support early phase and translational studies across a wide range of dermatology & rheumatology indications. Here are some examples of indications we focus on:
Indero successfully managed a Phase 1 clinical trial testing a systemic (oral) treatment for atopic dermatitis. The study included both healthy participants and those with AD, utilizing a FIH single dose escalation and multiple dose escalation (SAD/MAD) design (n=72) and a proof-of-concept (PoC) cohort (n=31). Conducted across 12 sites in the U.S. and one in the Netherlands, the study procedures included biopsy, tape stripping, and PK.
Wherever You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
